Diroximel Fumarate
CAS 915087-33-1 8 FDA-DMF suppliersSmall Molecule
Overview
Diroximel Fumarate is an oral medication used to treat relapsing forms of multiple sclerosis (MS) in adults. It is a prodrug that is rapidly converted into monomethyl fumarate, which exerts anti-inflammatory effects.
Therapeutic areas
Multiple Sclerosis
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.